Human Genome Epidemiology Literature Finder
|
Records 1 - 25 (of 25 Records) |
| Query Trace: Peptic Ulcer and CYP2C19[original query] |
|---|
| Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. The American journal of gastroenterology 2003 Nov 98 (11): 2403-8. Take Susumu, Mizuno Motowo, Ishiki Kuniharu, Nagahara Yasuhiro, Yoshida Tomowo, Inaba Tomoki, Yamamoto Kazuhide, Okada Hiroyuki, Yokota Kenji, Oguma Keiji, Shiratori Yasus |
| Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Alimentary pharmacology & therapeutics 2003 Jan 17 (2): 259-64. Kawabata H, Habu Y, Tomioka H, Kutsumi H, Kobayashi M, Oyasu K, Hayakumo T, Mizuno S, Kiyota K, Nakajima M, Kimoto K, Inokuchi H, Kawai |
| Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Alimentary pharmacology & therapeutics 2005 Nov 22 (10): 1033-40. Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A, Ishizaki |
| Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients. European journal of clinical pharmacology 2006 Oct 62 (10): 877-80. Kurzawski Mateusz, Gawro?ska-Szklarz Barbara, Wrze?niewska Joanna, Siuda Andrzej, Starzy?ska Teresa, Dro?dzik Mar |
| Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. Therapeutic drug monitoring 2008 Feb 30 (1): 46-51. Miura Masatomo, Satoh Shigeru, Inoue Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Suzuki Toshio, Habuchi Tomono |
| [Polymorphism of cytochrome P-450 gene in the light of Helicobacter pylori eradication efficiency]. Klinicheskaia meditsina 2009 87 (2): 35-9. Maev I V, Momynaliev K T, Oganesian T S, Govorun V M, Kucheriawy? Iu A, Selezneva O |
| Blood concentration of pantoprazole sodium is significantly high in hepatogenic peptic ulcer patients, especially those with a poor CYP2C19 metabolism. Journal of digestive diseases 2009 Feb 10 (1): 55-60. Shao Jian Guo, Jiang Wen, Li Ke Qing, Lu Jian Rong, Sun Yuan Yu |
| Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer. Journal of the Chinese Medical Association : JCMA 2010 Apr 73 (4): 188-93. Lay Chii-Shyan, Lin Chun-Jung, Lin Jiun-Ro |
| Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole. European journal of clinical pharmacology 2010 Jul 66 (7): 681-7. Gawro?ska-Szklarz Barbara, Siuda Andrzej, Kurzawski Mateusz, Bielicki Dariusz, Marlicz Wojciech, Dro?dzik Mar |
| The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people. Journal of clinical pharmacy and therapeutics 2010 Dec 35 (6): 713-22. Zhang L, Mei Q, Li Q S, Hu Y M, Xu J |
| CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. Clinical pharmacology and therapeutics 2012 Oct . Musumba CO, Jorgensen A, Sutton L, Van Eker D, Zhang E, O'Hara N, Carr DF, Pritchard DM, Pirmohamed M |
| Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective. Acta gastro-enterologica Belgica 2014 Mar 77 (1): 3-7. Sezgin Orhan, Barlas I Omer, Uçbilek Enver, Yengel Emre, Altinta? Eng |
| Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism. Current pharmaceutical design 2015 Sep . Shiotani Akiko, Fujita Yoshihiko, Nishio Kazu |
| Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert review of gastroenterology & hepatology 2015 Oct 1-13. Miftahussurur Muhammad, Yamaoka Yosh |
| Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer. Asian Pacific journal of cancer prevention : APJCP 2014 15 (24): 10957-60. Jainan Wannapa, Vilaichone Ratha-Ko |
| Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication. Basic & clinical pharmacology & toxicology 2016 Sep . Karaca R O, Kalkisim S, Altinbas A, Kilincalp S, Yuksel I, Goktas M T, Yasar U, Bozkurt A, Babaoglu M |
| [HIGH FREQUENCY OF CYP2C19 ULTRARAPID METABOLIZERS IN RUSSIAN PATIENTS WITH PEPTIC ULCER]. E?ksperimental'nai?a? i klinicheskai?a? gastroe?nterologii?a? = Experimental & clinical gastroenterology 2015 (6): 11-5. Denisenko N P, Sychev D A , Sizova Zh M, Grachev A V, Velikolug K |
| Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients. Pharmacogenomics and personalized medicine 2017 10 10 253-259. Denisenko Natalia P, Sychev Dmitriy A, Sizova Zhanna M, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena |
| CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole. Pharmacogenomics and personalized medicine 2018 11 107-112. Denisenko Natalia P, Sychev Dmitriy A, Sizova Zhanna M, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena |
| Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring. Journal of gastroenterology and hepatology 2019 7 34 (12): 2112-2117. Deguchi Hisato, Yamazaki Hajime, Yamamoto Yosuke, Fukuhara Shunic |
| CYP2C19*2 polymorphism in Polish peptic ulcer patients. Pharmacological reports : PR 2018 Dec 71 (2): 272-275. Sa?agacka-Kubiak Aleksandra, ?ebrowska-Nawrocka Marta, Jele? Agnieszka, Mirowski Marek, Balcerczak E |
| Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy. The Korean journal of internal medicine 2019 12 35 (3): 574-581. Chang Young Woon, Park Yoo Min, Oh Chi Hyuk, Oh Shin Ju, Cho Jun-Hyung, Kim Jung-Wook, Jang Jae-You |
| Association of CYP2C19, TNF-?, NOD1, NOD2, and PPAR? polymorphisms with peptic ulcer disease enhanced by Helicobacter pylori infection. Saudi medical journal 2021 Jan 42 (1): 21-29. Al-Eitan Laith N, Almomani Fouad A, Al-Khatib Sohaib |
| Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study. Chinese medical journal 2022 12 135 (24): 2941-2949. Zhu Huiyun, Pan Xue, Zhang Li, Sun Hongxin, Fan Huizhen, Pan Zhongwei, Huang Caibin, Shi Zhenwang, Ding Jin, Wang Qi, Du Yiqi, Lyu Nonghua, Li Zhaosh |
| Effect of MDR1 C3435T and CYP2C19 genetic polymorphisms on the outcome of Helicobacter pylori eradication treatment in children with gastritis and peptic ulcer, Vietnam. BMC pediatrics 2024 7 24 (1): 464. Loan Le Thi Thuy, Liem Thanh Nguyen, Hoang Anh Vu, Nghia An Nguyen, Tuan Anh Nguy |
- Page last reviewed:Feb 1, 2024
- Content source: